More survive Breast Cancer if more vitamin D – 2X fewer deaths with just 30 ng -meta-analysis March 2014

Meta-analysis of Vitamin D Sufficiency for Improving Survival of Patients with Breast Cancer

Anticancer Research March 2014 vol. 34 no. 3 1163-1166
SHARIF B. MOHR 1⇑, EDWARD D. GORHAM 1,2, JUNE KIM 1, HEATHER HOFFLICH 2 and CEDRIC F. GARLAND 1,2
1 Scientific Programs Office, Code 01A, Naval Health Research Center, San Diego, CA, U.S.A.
2 Department of Family and Preventive Medicine 0620, University of California, San Diego, La Jolla, CA, U.S.A.
Correspondence to: Sharif Mohr, Scientific Programs Office, Code 01A, Naval Health Research Center, San Diego, CA 92106, U.S.A. sbmohr75@gmail.com

Background/Aim: To determine whether higher serum 25-hydroxyvitamin D [25(OH)D] at diagnosis is associated with longer survival of patients with breast cancer.

Materials and Methods: A meta-analysis was performed of five studies of the relationship between 25(OH)D and mortality from breast cancer. A pooled hazard ratio was calculated using a random-effects model. The Der Simonian-Laird test was used to assess homogeneity.

Results: Higher serum concentrations of 25(OH)D were associated with lower case-fatality rates after diagnosis of breast cancer. Specifically, patients in the highest quintile of 25(OH)D had approximately half the death rate from breast cancer as those in the lowest.

Conclusion: High serum 25(OH)D was associated with lower mortality from breast cancer. Serum 25(OH)D in all patients with breast cancer should be restored to the normal range (30-80 ng/ml), with appropriate monitoring. Clinical or field studies should be initiated to confirm that this association was not due to reverse causation.



Image Image


PDF is attached at the bottom of this page

Studies in all 3 categories: Breast Cancer, Meta-analysis and Mortality


derived from Grassroots 2013

All Breast Cancer Meta-analysis studies in VitaminDWiki

Studies in all 3 categories: Cancer, Meta-analysis and Mortality

7798 visitors, last modified 24 Feb, 2019,
Printer Friendly Follow this page for updates